Daqian Wan

407 total citations
30 papers, 334 citations indexed

About

Daqian Wan is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Daqian Wan has authored 30 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Biomedical Engineering. Recurrent topics in Daqian Wan's work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (3 papers) and Circular RNAs in diseases (3 papers). Daqian Wan is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (3 papers) and Circular RNAs in diseases (3 papers). Daqian Wan collaborates with scholars based in China, India and United States. Daqian Wan's co-authors include Songtao Ai, Wenqi Song, Yan Su, Chaoyin Jiang, Yimin Chai, Yang Qu, Jiezhi Dai, Lei Shao, Liming Cheng and Ting Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and ACS Applied Materials & Interfaces.

In The Last Decade

Daqian Wan

27 papers receiving 331 citations

Peers

Daqian Wan
Zhong-Hua Chen China
Tonggang Qi China
Yuhao Zhao China
Ke Tian China
Wendong Guo China
Zhijian Yang China
Youqiang Sun China
Xiangde Zhao China
Zhu Wang China
Zhong-Hua Chen China
Daqian Wan
Citations per year, relative to Daqian Wan Daqian Wan (= 1×) peers Zhong-Hua Chen

Countries citing papers authored by Daqian Wan

Since Specialization
Citations

This map shows the geographic impact of Daqian Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daqian Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daqian Wan more than expected).

Fields of papers citing papers by Daqian Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daqian Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daqian Wan. The network helps show where Daqian Wan may publish in the future.

Co-authorship network of co-authors of Daqian Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Daqian Wan. A scholar is included among the top collaborators of Daqian Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daqian Wan. Daqian Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wan, Daqian, et al.. (2024). Mn-ZIF nanozymes kill tumors by generating hydroxyl radical as well as reversing the tumor microenvironment. Frontiers in Pharmacology. 15. 1441818–1441818. 2 indexed citations
3.
Zhu, Dan, Zhengjia Zhang, Guozhi Zhang, et al.. (2024). Experimental and clinical validation of an artificial intelligence metal artifact correction algorithm for low-dose following up CT of percutaneous vertebroplasty. Quantitative Imaging in Medicine and Surgery. 14(9). 6843–6855. 1 indexed citations
4.
5.
Wang, Yanhong, et al.. (2022). CD137 Regulates Bone Loss via the p53 Wnt/β-Catenin Signaling Pathways in Aged Mice. Frontiers in Endocrinology. 13. 922501–922501. 11 indexed citations
6.
Zhao, Zitong, et al.. (2022). Screening for MicroRNA combination with engineered exosomes as a new tool against osteosarcoma in elderly patients. Frontiers in Bioengineering and Biotechnology. 10. 1052252–1052252. 2 indexed citations
7.
Zhou, Haichao, et al.. (2022). Integrated Bioinformatics and Experimental Analysis Identified TRIM28 a Potential Prognostic Biomarker and Correlated with Immune Infiltrates in Liver Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine. 2022. 1–17. 5 indexed citations
8.
Wan, Daqian, et al.. (2021). Activation of 4-1BB signaling in bone marrow stromal cells triggers bone loss via the p-38 MAPK-DKK1 axis in aged mice. Experimental & Molecular Medicine. 53(4). 654–666. 5 indexed citations
9.
Jiang, Yu, Yuping Li, Yue Pan, et al.. (2020). Deficient Regulatory Innate Lymphoid Cells and Differential Expression of miRNAs in Acute Myeloid Leukemia Quantified by Next Generation Sequence. SHILAP Revista de lepidopterología. 2 indexed citations
10.
Wan, Daqian, Yang Qu, Lei Zhang, Songtao Ai, & Liming Cheng. (2020). The lncRNA LINC00691 Functions as a ceRNA for miRNA-1256 to Suppress Osteosarcoma by Regulating the Expression of ST5. OncoTargets and Therapy. Volume 13. 13171–13181. 16 indexed citations
11.
Yu, Ting, Deliang Chen, Li Zhang, & Daqian Wan. (2019). microRNA-26a-5p Promotes Proliferation and Migration of Osteosarcoma Cells by Targeting HOXA5 in vitro and in vivo. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Chen, Dexin, et al.. (2019). <p>microRNA-26a-5p Promotes Proliferation and Migration of Osteosarcoma Cells by Targeting <em>HOXA5</em> in vitro and in vivo</p>. OncoTargets and Therapy. Volume 12. 11555–11565. 11 indexed citations
13.
Chen, Dexin, Daqian Wan, Rongying Wang, et al.. (2018). Multimodal Nanoprobe Based on Upconversion Nanoparticles for Monitoring Implanted Stem Cells in Bone Defect of Big Animal. ACS Biomaterials Science & Engineering. 4(2). 626–634. 13 indexed citations
14.
Wang, Yanmao, Daqian Wan, Runhua Zhou, et al.. (2017). Geraniin inhibits migration and invasion of human osteosarcoma cancer cells through regulation of PI3K/Akt and ERK1/2 signaling pathways. Anti-Cancer Drugs. 28(9). 959–966. 30 indexed citations
15.
16.
17.
Wang, Ting, Daqian Wan, Lei Shao, Jiezhi Dai, & Chaoyin Jiang. (2015). Notoginsenoside R1 stimulates osteogenic function in primary osteoblasts via estrogen receptor signaling. Biochemical and Biophysical Research Communications. 466(2). 232–239. 32 indexed citations
18.
Wan, Daqian, Chaoyin Jiang, Xin Hua, Ting Wang, & Yimin Chai. (2015). Cell cycle arrest and apoptosis induced by aspidin PB through the p53/p21 and mitochondria-dependent pathways in human osteosarcoma cells. Anti-Cancer Drugs. 26(9). 931–941. 12 indexed citations
19.
Yu, Yiyi, et al.. (1998). [The relationship between nm23-H1 loss of heterozygosity and metastasis in hepatocellular carcinoma].. PubMed. 36(3). 161–3. 1 indexed citations
20.
Wan, Daqian, et al.. (1995). [cDNA clones of differential expression between human normal liver tissue and hepatocarcinoma].. PubMed. 75(10). 606–8, 639. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhong-Hua Chen Breakdown of academic impact, for papers by Tonggang Qi Breakdown of academic impact, for papers by Yuhao Zhao Breakdown of academic impact, for papers by Ke Tian Breakdown of academic impact, for papers by Wendong Guo Breakdown of academic impact, for papers by Zhijian Yang Breakdown of academic impact, for papers by Youqiang Sun Breakdown of academic impact, for papers by Xiangde Zhao Breakdown of academic impact, for papers by Zhu Wang
Rankless by CCL
2026